toxicity bioassays: unleashing the power of real-time cell analysis for health risk assessment
Published 9 years ago • 934 plays • Length 52:41Download video MP4
Download video MP3
Similar videos
-
2:06
xcelligence – a transformative technology in cancer research (2/2)
-
5:26
agilent xcelligence rtca esight at aacr 2019
-
4:03
acea's xcelligence dp analyzer
-
24:33
evaluating drug induced proarrhythmic risk using the cardioecr system
-
1:15
cardiotoxicity screening using hipsc cardiomyocytes and acea's xcelligence cardioecr sysem
-
30:57
applications & limitations of bioassay methods for contaminants of emerging concern
-
5:09
xcelligence real time cell analysis (rtca) esight product video
-
3:44
uncover anti-viral drug effects with the xcelligence real time cell analysis (rtca) esight
-
0:16
rifng timecourse on xcelligence rtca esight
-
0:54
“new methods for toxicity assessment mean new uncertainties”
-
22:13
an in vitro-based integrated approach for inhalation toxicity assessment
-
6:18
gaining greater insight into mechanisms of toxicity through single and multi-omics approaches
-
1:00:13
measuring immune cell killing dynamics through real time impedance and live cell imaging
-
2:05
checkpoint inhibitor research challenges
-
0:25
monitoring tumor cell killing and ifng production by t cells on xcelligence rtca esight
-
2:20
do you know what your cells are doing?
-
16:23
bioanalysis of unstable analytes in pharmacokinetic be studies for andas - bioanalysis 2020
-
10:16
2021 metroflow annual meeting agilent technologies